Working with others to address major challenges enables me to help people with vision problems.
Where I see patients (1)
Selected research
-
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100.
American journal of ophthalmology
-
Longitudinal Assessment of Cone Structure, Choriocapillaris, and Retinal Sensitivity in Choroideremia.
Investigative ophthalmology & visual science
-
Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.
NEJM evidence
Clinical trials
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
To evaluate the safety and tolerability of a single dose of ACDN-01 when administered to participants with ABCA4-related retinopathy.
Recruiting
More about this studyRetinal Imaging in Patients With Inherited Retinal Degenerations
The current study will assess cone spacing twice at baseline and every 6 months for 30 months. The primary outcome will be measured at 24 months.
Recruiting
More about this studyEyeConic: Qualification for Cone-Optogenetics
Number of participants with preserved central retinal volume
Recruiting
More about this studyDoctors see bright future for augmented sight
With the help of Dr. Duncan's research into augmented sight, blind and low-vision patients can see light for the first time in years.
Contact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program
